Current Pharmaceutical Biotechnology

Luisa Fiandra, PhD is Assistant Professor in Clinical Biochemistry at the Department of Biotechnology and Biosciences, University of Milano Bicocca. Currently, she is devoted to the use of advanced 3D cellular models and in vivo models for the validation of latest generation Nano formulated therapies directed towards tumor pathologies. She is the author of more than 40 articles and also member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), Italian Society of Clinical Biochemistry (SiBioC), BioNanoMedicine Center “NANOMIB” (Italy) and Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R, Italy).

Prof/Dr. Cheorl-Ho Kim has received his MS and PhD in The University of Tokyo during the period of 1985-1990. Currently, since 2006 he is a professor in Department of Biological Sciences, College of Science, Sungkyunkwan University, Korea. He has successfully completed his Administrative responsibilities as Genome Program Head, Korea Research Institute of Bioscience and Biotechnology on 1990-1996 and Chairman, Department of Biochemistry and Molecular Biology, COM, Dongguk University during 1996-2006. His research has included the moleculr biology of gene expression, Golgi glycosyltransferase, oncognenesis, cancer metastasis and angiogenesis. He has authored 368 research articles/books with H-index 54. He is a member of International Scientific Advisory Board Member, International Symposium for Glycosyltransferases (GlycoT 2006), IUBMB symposium, Tsukuba and International Symposium for Glycosyltransferases (GlycoT 2008), Emory University, GA, USA.

Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 44,000 citations of his papers with H-index of 96. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. He received more than $30 M from the governmental and industrial sources in research funding. He has multiple honors and awards and in 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.

Dr. Blum serves as Chairman of Geneus Sciences LLC., His concept of Reward Deficiency Syndrome is being embraced by world leaders in science and is part of the DSM –V, ASAM, Sage Encyclopedia of abnormal and clinical psychology 2017. Dr, Blum is credited with the DRD2 gene discovery and addictive diseases. He serves as Editor-in-Chief in Journal of Reward Deficiency Syndrome (he coined) and Addiction Sciences and Co-EIC of Journal of Neuroimaging in Psychiatry and Neurology (USG). He is currently serving on fourteen other prestigious journal’s Editorial Boards. He has published over 450 articles, 16 books, numerous patents and received many awards (Life-Time Achievements) for his seminal discoveries. He is the founding President of United Scientific Group (USG).

Dr. Guo is a professor at Shanghai University of Traditional Chinese Medicine and vice director in the Department of Anatomy. He received his doctoral degree from Fudan University in 2010 and worked in Boston Children's Hospital as a visiting scholar between 2014-2015. He has hosted two National Nature Science Foundation which are related to the regeneration medicine. His research interests are: stem cell differentiation and transplantation, stem cell and biomaterials or traditional Chinese medicine.

Shiwei Hu, is an Associate Professor of Zhejiang Ocean University, Deputy director of the Marine Biological Resources Deep Processing Institute, and has conducted studies on the structural analysis and functional assessment of marine bioactive substances. He has published more than 100 manuscripts in high quality journals in the field, such as J Funct Food, Food Func, J Food Drug Anal, Int Immunopharmacol, and has been awarded multiple federal grants (total of more than ￥2 million China RMB) to support the research program. In addition, he has been the reviewer for more than 20 high quality internationally renowned journals.

Shanfa Lu is a professor and Xiehe scholar at the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College. He obtained his PhD from Institute of Botany, Chinese Academy of Sciences. He completed international post- graduate university course at Osaka University of Japan, did Postdoctoral Research at Michigan Technological University and North Carolina State University (NCSU) of USA, and was a Research Assistant Professor at NCSU. He has published more than ninety papers, contributed six book chapters, edited three books, reviewed manuscripts for more than thirty international journals, evaluated grant proposals for thirteen Chinese and international funds, and is on the editorial board of six international journals.

Dr. Natália Martins (PhD, Researcher, Professor) has vast experience in dietetics and nutrition, natural product chemistry and biochemistry, drug discovery, phytochemistry, phytopharmacology, functional foods, and nutraceuticals. She has been increasingly focused on the use of naturally occurring bioactives for human health and treatment. Natália has held several specializations in evidence-based medicine, clinical nutrition, and personalized medicine. She has worked as a university professor since 2017, was also an advisor of several MSc and PhD theses, and is a member of the evaluation panel of the College of Nutritionists (Porto, Portugal). She has participated in various research projects, received several grants and awards, and published more than 120 articles in peer-reviewed, highly reputed, international journals, written 10 book chapters, and presented more than 40 communications at national and international conferences. Dr. Martins is also a member of the Council for Nutritional and Environmental Medicine (CONEM, Norway), reviewer for more than 50 highly reputed international journals, invited reviewer for several book publishers, and editorial board member of several international journals. She has also edited several special issues and research topics in highly reputed journals and is currently editing several books for renowned publishers.

Prof. Heinz Peter Nasheuer is Personal Professor in Biochemistry at the National University of Ireland (NUI) Galway, Galway, Ireland. He completed his PhD at the Max Planck Institute in Göttingen, Germany, and did postdoctoral studies at the Stanford University School of Medicine, California, USA. He has published more than 80 papers in peer-reviewed journals. His research interests are the mecha¬nisms of cell cycle control, DNA replication and DNA damage signalling. Recently he established that small RNAs regulate eukaryotic DNA replication. He has a year-long experience in recombinant DNA technologies including protein expression in variety of cell-based systems.

Dr. Yan Pei obtained a Doctor of Engineering from the Kyushu University, Fukuoka, Japan. He received the B.Eng. and M.Eng. degrees from Northeastern University, Shenyang, China. He is currently working at the University of Aizu as an Associate Professor. His research interests include Evolutionary Computation, Machine Learning, and Software Engineering.

Dr. Sahoo obtained a doctorate (Ph.D.) in chemistry from the University of Delhi, Delhi, India. Presently, Dr Sahoo is a scientist at the Institute of Life Sciences, Bhubaneswar, India. He has nearly 20 years of experience in the research related to nanotechnology based drug delivery to cancer. Dr Sahoo has authored more than 80 manuscripts, 5 patents and edited one book “Nanotechnology in Health Care”

Donghua Xu is a professor and excellent scholar at the Development of Immunology and Rheumatology of the First Affiliated Hospital, Weifang Medical University, Weifang, China. She obtained her PhD from Nanjing Medical University, Nanjing, China. She has published more than thirty papers in peer-reviewed journals, edited three books, reviewed manuscripts for more than ten international journals, and evaluated grant proposals for ten Chinese and international funds. Her main research interests are target and molecular mechanism research in immunity, inflammation, and cancer-related diseases. In particular, she and the colleagues have found several well documented noncoding RNAs involved in cancer and rheumatic diseases.

Dr. Torre is an Associate Professor in the Department of Public Health at the Sapienza University, Rome. He got the Degree in Medicine, specialised in Hygiene and Preventive Medicine (Epidemiology and Public Health), Master of Science in Epidemiology and Doctor of Science in Epidemiology. His main research activities including design, conduct and analysis, are in the Public Health Epidemiology and Occupational health areas. He has been the President of the EUPHA Section of Public Health Epidemiology. He has published 480 scientific articles on national and international peer reviewed papers.

Dr. Luca Agnifili is Research Fellow at the National High-Tech Eye Center of the University G. d’Annunzio of Chieti-Pescara, Italy. His main field of interest is Glaucoma, with research projects focusing on ocular surface changes induced by anti-glaucoma medications, tear film proteomics, patho-physiology of aqueous humor outflow, and imaging of the anterior segment of the eye. He represents one the most expert worldwide of in vivo confocal microscopy in glaucoma. His research activity resulted in more than 100 publications, with a current H-index of 19. Dr Agnifili is invited speaker in several glaucoma meetings and trained numerous residents in ophthalmology and postdoctoral research fellows".

The experienced researcher with a demonstrated history of researching in the field of pharmaceutical sciences. Skilled in clinical research, Animal models, Cellular models, Scientific writing & publishing. He has focused on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many originals and reviews in high-quality journals and selected as a recognized international editor and peer reviewer by famous publishers. In 2019, Dr. Amirhossein Ahmadi certificates for placing in the top 1% of reviewers in Cross-Field on Publons global reviewer database.

Pablo Taboada (PT) gained his PhD in 1999 from the U. of Santiago of Compostela (USC) (Spain). PT has co-authored 163 papers included in JCR (h-index 30, >2900 citations) and has participated as PI or team member in more than 27 national/international competitive research projects and contracts with different public and private institutions. He received a Ramón y Cajal fellowship by the Spanish Ministry of Science and Innovation to incorporate his knowledge about block copolymers as a new research line at the USC.

Dr. Athar Ata is a Chair person of Department of Chemistry, University of Winnipeg, Canada. Professor Ata’s research skills involved a. Isolation of bioactive compounds from natural sources using a wide variety of chromatographic techniques as well as bioassay guided fractionation methods, b. microbial transformations of bioactive natural products using liquid culture of bacteria and fungi at small and large scales, c. Chemical modification of bioactive natural products to study structure-activity relationships. His research has resulted in about 74 peer-reviewed articles in scientific journals. He is a member of American Chemical Society and got Clifford J. Robson Memorial Award for Excellence in Teaching in 2007-2008. He is an Editorial Board member of Current Pharmaceutical Biotechnology.

Sofia Avnet graduated in Medical Biotechnology and in Cellular and Molecular Biology and started research on bone tumors at the Kimmel Cancer Inst., Philadelphia, PA and at Rizzoli Orthopaedic Inst. (IOR), Bologna, Italy, and continued her study on cancer molecular targeting at the Inst. for Cancer Care and Research, Candiolo, Italy. After her PhD, She was a Research fellow at the Univ. of Turku, Finland and a visiting researcher at Lady Davis Inst. for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec in 2007. From 2008, Avnet became a staff Biotechnologist at Orthopaedic Pathophysiology and Regenerative Medicine Lab at IOR and her research activity focused on bone tumor biology and the role of metabolic reprogramming during the stroma-tumor interaction.

Dr. Ajay K Banga completed his PhD program from Rutgers University. His research is focused on the formulation development and drug delivery systems and to investigate traditional and non-traditional approaches for topical and transdermal delivery of pharmaceuticals and cosmeceuticals, especially for water soluble small conventional molecules and macromolecules. His laboratory has received over 80 funded projects from the industry related to skin delivery systems.

Dr. Biswanath Bhunia received a PhD in 2012 from National Institute of Technology Durgapur’s Biotechnology Program. Following completion of his PhD, Dr. Bhunia joined to academia as a tenure-track Assistant Professor within the Department of Bioengineering at the National Institute of Technology Agartala in 2013. Dr. Bhunia is working on various secondary metabolite production using fungal, bacteria, cyanobacteria, algae etc. He has authored or co-authored 60 peer-reviewed papers, ten book chapter, and presented at numerous national and international conference on topics ranging from bioprocess engineering, bioinformatics, enzyme and microbial technology, advanced purification process and modelling. Dr. Bhunia’ teaching interests are focused on Bioprocess Engineering, Environmental Biotechnology, and Bioinformatics.

Dr. Cesar Lopez-Camarillo is currently acting as full professor for Genomics Sciences Program at the Autonomous University of México since 2003. His research is focused on the identification and functional analysis of microRNAs, lncRNAs and proteins deregulated in breast cancer using omics approaches. He is interested in the identification of novel therapeutic targets and elucidation of molecular mechanisms of tumorigenesis. He also works on nutrigenomics evaluating the chemopreventive role and impact on transcriptome/methylome of dietary polyphenols in cancer. Dr. Lopez-Camarillo has also published more than 100 papers in International journals.

Dr. Carpineto received the degree in Medicine and Surgery from the University "G. D'Annunzio" of Chieti, Italy, in 1989. He did specialization in Ophthalmology from the University of Catania, Italy, in 1993. He became Associate Professor of Ophthalmology, Head of Specialization School of Ophthalmology at the University “G. d’Annunzio of Chieti-Pescara, Italy. Author of 270 scientific papers, 97 of which peer reviewed and cited by Journal Citation Report and Scopus. Reviewer of the Italian Instruction, University and Research Ministry (MIUR) Reviewer of the Register of Expert Peer Reviewers for Italian Scientific Evaluation (REPRISE) Vitreoretinal national expert of Italian Society of Ophthalmology (SOI).

Dr. Giovanni Cizza obtained his Ph.D. from the University of Firenze Firenze, Italy. He has presently been working as a Senior Director, Clinical Development, Biopharmaceuticals. His subject areas are Medicine Biochemistry, Genetics and Molecular Biology Neuroscience Pharmacology, Toxicology and Pharmaceutics Immunology and Microbiology Agricultural and Biological Sciences. He has contributed 94 publications, having around 3840 in different publications.

Cristoforo Comi received his M.D. degree from the University of Milan, Italy, board certification in neurology, and Ph.D. degree in molecular medicine from the University of Piemonte Orientale (UPO). He is Associate Professor of Neurology and Head of the Laboratory of Molecular Neurology at UPO, Novara, Italy. His area of expertise includes the molecular bases of neurodegenerative and neuroinflammatory diseases. His main research achievements are regarding the role of T-cell apoptosis in neuroinflammatory diseases and the study of proinflammatory genes and cytokines in neurodegenerative diseases. Current studies are concerned with the role of immunity and inflammation in chronic neurodegeneration, with a special focus on identifying biomarkers of disease progression.

Dr. del Pino since 2016, is an Assistant Professor and PI of BioNanoTools Laboratory of the Center for Research in Biological Chemistry and Molecular Materials at University of Santiago de Compostela. He received his M.S. in Physics from Universidad of Sevilla, and Ph.D. in Biophysics from Technical University of Munich. Before starting his own group at CiQUS, he has been a researcher in LMU, INA (University of Zaragoza), CIC biomaGUNE and Philipps-University of Marburg. His research focuses on design of functional nanomaterials for applications in Life Science, synthesis of inorganic /organic nanoparticles and applications in nanomedicine.

Martin Federico Desimone graduated in Pharmacy and Biochemistry from the University of Buenos Aires and received his Ph.D. degree from the same University. After a postdoctoral period in the University of the Basque Country, Spain, in 2008, he joined the Laboratoire Chimie de la Matiére Condensée de Paris. Actually, he is a CONICET researcher and holds a Full Professor position at the University of Buenos Aires, Argentina. His current focus is on the design of functional organic, inorganic and biological hybrid materials and to study the interactions of the nano- and microscale for biomedical and biotechnological applications.

Dr. Jesus received his Ph. D and M.D from School of Medicine Santiago DE Compostela. He is currently working as a Scientific Director in University of Santiago de Compostela. He was the first in the world to use GH to recover a young patient after diffuse axonal injury and severe sequels and first to promote full distal innervation in a child affected by Caudal Regression Syndrome and Sacral agenesis. He has received 25 awards in Research. He has an H-Index of 21 and serving as an Editorial Board Member of many scientific journals.

Prof. Nicola Di Daniele is a Full Professor of Internal Medicine at the University of Rome (Tor Vergata), Department of Systems Medicine. He is head of the Clinical Care Department of Medicine, he has expertise in arterial hypertension and clinical nutrition. In particular, he has been involved in studies investigating the effects of the Mediterranean Diet in the prevention of the metabolic syndrome, cardiovascular disease and its effects on longevity. He has also put efforts to identify novel risk markers for obesity, by investigating the role of polymorphic variants of some obesity related genes.

Dr. Doyle is Senior Principal Investigator of Protein Science at Bristol-Myers Squibb Pharmaceuticals, Inc. He has 25 years of drug discovery experience in biophysical characterization of protein drugs and targets. Michael earned his PhD in Protein Biophysical Chemistry at the University of Colorado, Boulder. He was a founding member of the Molecular Interactions Group of Association of Biomolecular Resource Facilities (ABRF), where he played a leading role in developing protein interaction systems to benchmark molecular interaction technologies across multiple laboratories. Michael has published 80 scientific articles and Co-Edited “Biocalorimetry 2: Applications of Calorimetry in the Biological Sciences.

Dr. Edward Eisenstein is an Associate Professor in the Fischell Department of Bioengineering at the University System of Maryland. He has obtained his PhD in Biochemistry from Georgetown University, Washington. His main interests are in the field of Biophysics, molecular interactions, gene-metabolite relationships in medicinal plants, molecular basis for plant disease resistance, plant metabolic engineering for improved biofuel production. Professor Eisenstein's laboratory is investigating a number of queries involving plants, considering their remarkable capacity to produce a complex array of interesting compounds, the way they respond to pathogens and disease, and also the feasibility of engineering their biosynthetic apparatus for applications ranging from human health to biofuel production.

Jonathan Engle is an accelerator physics and radiochemist specializing in radionuclide production for medical applications. His efforts focus on the formation of novel radionuclides, their isolation from cyclotron target materials, and their use in positron emission tomography imaging, basic science research, and industrial applications. He is the recipient of a 2017 Department of Energy Early Career Award to study the formation of novel radionuclides using vast spallation neutrons. Other current projects focus on the application of radiomanganese in tracking functional pancreatic beta cell mass and the use of Auger-emitting radionuclides for therapeutic treatment of human disease.

Dr. Massimilano Filosto has obtained his PhD in Neurosciences at University of Verona after a postdoctoral research fellowship at the Department of Neurology, Columbia University, New York, USA. He is a member of the Treat- NMD Neuromuscular Network. His main interests is in the field of Neuroscience are muscle, nerve and motor neuron diseases. His work focuses on metabolic myopathies,genotype/phenotyperelations,epigenetic and pathological findings in mitochondrial diseases and muscle glycogenoses. He is full Individual Member of the European Academy of Neurology and participates to expert panels in neuromuscular diseases, peripheral neuropathies and motor neuron diseases.

Dr. Fioravanti graduated in 1980 from the University of Siena (Italy) in Medical School with major in Endocrinology, Rheumatology. She did PhD in Experimental Rheumatology. She is the In-charge and Assistant of Professor of the Rheumatology Unit at the General Hospital “Le Scotte” of Siena. She holds the office since 2004 for high specialization in diagnosis and therapy of degenerative rheumatic diseases. She is involved in clinical and laboratory research with about 200 papers on scientific journals. She is also the co-author of 12 books dedicated to rheumatological disease and medical hydrology.

Dr. Carlos M. Franco completed his graduation in Veterinary Sciences in 1990, and obtained his Ph.D. degree in Nutrition and Bromatology in 1994. Dr. Franco is currently Full Professor, in the Department of Analytical Chemistry, Nutrition and Bromatology, at University of Santiago de Compostela, Santiago, Spain. His skills and expertise mainly lie in the subject areas of Chromatography, RNA, Mass Spectrometry, High-Performance Liquid Chromatography, Microbiology, Microbial Molecular Biology, Applied Microbiology, Antibiotic Resistance, Food Safety, etc. Dr. Franco, as an author/co-author, has published more than 105 articles in various journals, having over 1,755 total citations.

Fumiyuki Hattori has obtained Ph.D. from graduate school of science, Nagoya University. He has currently been working as an Associate Professor since 2012. He also works at the Department of Cardiology, Keio University School of Medicine. His subject areas are Biochemistry, Genetics and Molecular Biology Medicine Immunology and Microbiology Neuroscience Agricultural and Biological Sciences. He has contributed around 30 publications, having citations around 1904.

Dr. Gaikwad's research has been focused in the areas of Metabolomics, Metabolism, Modulation of Metabolic Pathways, Mass Spectrometry and its Applications, Chemical Carcinogenesis, Food and Disease Biomarkers, and Biomarker Synthesis. Steroidomics platform that he has recently developed is the first, most advanced and unique in the world. Using this platform, we can now measure all classes of steroids with enhanced precision and sensitivity. He has patented this technology.

Dr. Alessandra Gianoncelli is Assistant Professor (art. 24 c.3-b L. 240/10) of Pharmaceutical Chemistry, Laboratory of Proteomic, Department of Molecular and Translational Medicine, University of Brescia. She is the coordinator of proteomic laboratory at the Department Molecular and Translational Medicine at the University of Brescia. The research activity of Alessandra Gianoncelli is focused on the analysis of proteins, biotechnological drugs and biosimilars and small molecules in biological and natural matrix by mass spectrometry and liquid chromatography.

Daniel Gomez is a professor in the Biotechnology School at Quilmes National University (Argentina). He received his MD degree in Buenos Aires in 1986 and a Ph.D. degree in Medical Sciences in 1990. Using several technical approaches, Dr. Gomez in collaboration with Dr. Olivero found that AZT binds preferentially to telomeres, inhibits telomerase and enhances tumor cell senescence and apoptosis after AZT treatment in breast mammary adenocarcinoma cells. Since then, several studies have considered AZT for telomerase inhibition and have led to potential clinical strategies for anticancer therapy. He is working on a new set of inhibitors using rational design techniques. Dr. Gomez is the author of more than 120 international peer-reviewed publications and seven patents of invention.

Antonio Gonzalez-Bulnes is currently Senior Researcher and Head of the Comparative Physiology Lab at INIA. His research activities has been funded by several national and international funding bodies and its impact is determined by 187 SCI papers, 12 PhD Thesis and several books and book chapters. He has been actively involved in international collaborations and is currently member of the Managing Committee and leader of Working Group at the EU COST Action BM1308 “Sharing Advances on Large Animal Models”. He is also actively working in Research Ethics and is member of the Scientific Ethic Committee of the OPIs of the Spanish Government.

Prof. Roberta Granese received her degree in Medicine from University of Messina, Italy, in 1998. She did specialization in Gynecology and Obstetrics from the University of Messina, Italy, in 2003 and received her PhD degree in “Therapeutic alternative to the hormonal therapy in the treatment of climacteric syndrome” from University of Messina, Italy, in 2008. Currently, she is a Senior Lecturer in the U.O.C. of Obstetrics and Gynecology in the Department of Human Pathology in Adulthood and Childhood “G. Barresi” at the University Hospital of Messina, Italy. Dr. Granese has numerous contributions and notable scientific publications to her credit.

Dr. Habtemariam received his BSc degree in Biology from the University of Addis Ababa and his Master’s degree (combined-studies) in Pharmacology and Phytochemistry from the University of Strathclyde, Glasgow. He stayed on at Strathclyde to study at doctoral level, studying the pharmacology and chemistry of herbal medicines and obtained his PhD in this area of research. With a Principal Lecturer post at Greenwich, Dr. Habtemariam has been a leader of taught programmes and research on bioassays & natural products-based drug development. Drug discovery, primarily from natural sources, is his main area of research, while he is running herbal medicines analysis as a core area of consultancy services.

Dr. Hong is currently an Assistant Professor of Radiology at University of Michigan and a faculty member at UM Center for Molecular Imaging (CMI). He obtained a doctorate (Ph.D.) in Biochemistry from Nanjing University, China. He has nearly 10 years of experience in the research of molecular imaging, particularly PET imaging, and his research is also focused on the development of novel functional nanomaterials for cancer theranostics. Dr. Hong has authored more than 90 manuscripts, 4 patents, 8 book chapters, and co-edited “Protein-Protein Interactions – computational and experimental tools”. Dr. Hong is currently the editorial board member of Current Pharmaceutical Biotechnology, published by Bentham Science Publishers.

Dr. Xudong Huang is the Co-director for Neurochemistry Laboratory at Psychiatry Department of Massachusetts General Hospital (MGH), a teaching affiliate of Harvard Medical School (HMS). Dr. Huang received his Ph.D. from MIT. He performed his postdoctoral work at MGH/HMS. His current research thrust is centered upon: (i) validating potential link of environmental stressors such as exposure of metals and engineered nanomaterials (ENMs) and neurodegeneration; (ii) Alzheimer’s genomics and image data analysis using clinical data and machine- and deep- learning-based big data analytics; (iii) Discovery of novel theranostics. Dr. Huang serves on scientific advisory and editorial boards for many research foundations and scientific journals.

Prof. Jerzy Jankun is Full Professor in Urology Department at the University of Toledo USA. He extensively studied proteolysis in carcinogenesis. In particular, the research activity of Prof. Jankun involves the inhibition of plasminogen activation system and metaloproteinaseswith particular focus on the treatment of variety of cancers. He also works on applications of plasminogen activator system in blood clotting and on plasminogen activation inhibitor deficiency. He is author of over 125 scientific publications and 8 patents (USA, Canada, Germany, Netherlands, Poland and others).

Dr. Lutz Jermutus worked on methods to evolve protein variants with novel functionalities in the test tube during his PhD. The innovative drug modalities that we worked on ultimately contributed to over half of our research portfolio. He then had the opportunity to take one of the resulting drug leads, a dual agonist peptide, into clinical trials and help transform it into a new medicine. Dr. Jermutus is probing human biology with a range of modalities (small molecules, peptides, anti-sense nucleotides, siRNAs, proteins, antibodies) across all our indications (cardiovascular disease, heart failure, kidney diseases, liver and metabolic diseases).

Prof. Nagendra is an Associate Professor of Biomedical Sciences at the Kwangwoon University at Seoul, South Korea. He received a PhD degree in Biomedical Sciences from Delhi University in 2010. Prof. Nagendra research at Kwangwoon University is primarily focused on plasma medicine, cancer biology, immune-modulation, chemical biology and nanotechnology. Prof. Nagendra has authored >60 peer-reviewed articles (total citation: >1227; H-index: 20). Prof. Nagendra has served as the Editorial Board and Reviewer of >30 journals, and participated in many special issues of renowned journals as a guest editor.

Veysel Kayser is an Associate Professor in the Sydney School of Pharmacy at the University of Sydney. He received his B.Sc. from Hacettepe University (Turkey), Ph.D. from the University of Leeds (UK). He then performed post-doctoral research at the Max-Planck Institute (Germany) and at MIT (US). Before joining the University of Sydney, he was a senior staff scientist at MIT.

Dr Masood Alam Khan is an Associate Professor in the College of Applied Medical Sciences at Qassim University, Buraydah, Saudi Arabia. He obtained his Ph.D. degree in 2004 in the field of Biotechnology from the Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India. He got his postdoctoral training (June 2004 to December 2009) in the department of Microbiology and Immunology from Indiana University School of Medicine, Indianapolis, USA. During postdoctoral training, he studied the immune evasion mechanisms adopted by viruses and tumors. His research interests include NKT cells and innate immunity, antigen presentation, Viral and Cancer Immunology, Vaccine and Drug delivery. He is also the member of American Association of Immunologists (AAI), Society of Leukocyte Biology and Microbiology Society.

Dr. Reza Khodarahmi (Professor in Biochemistry) was born in Nahavand-Iran, 1974. He received his Bsc degree in general Biology from the Razi University-Kermanshah and then graduated in Biochemistry (Msc) from the Tarbiat Modarres University-Tehran. He received his PhD degree in 2005 from the Institute of Biochemistry and Biophysics, University of Tehran for his studies on the effects of artificial chaperones on protein misfolding and aggregation. Since 2007, he has held a position in the school of Pharmaceutical Sciences (and Medical Biology Research Center), Kermanshah University of Medical Sciences. His research interests focus on the in vitro characterization of oxidative events accompanying amyloid aggregation, drug-protein interaction and enzyme inhibition, using both experimental and computational tools.

Prof. SEOK JUNG KIM is a professor of orthopedic surgery at the Catholic University, Korea. As a vice-dean of catholic university, he served his effort and idea for development and progression of educational system. He also served as director of the cell therapy center, UJB St. Mary’s hospital, Catholic University of Korea for 10 years. His main interest is ‘articular cartilage and bone regeneration’ for cartilage defect, osteonecrosis, fracture, non-union, etc. He treated fracture patients successfully using autologous cultured osteoblast in 2001, and this is world 1st case. He experienced more than 1000 cases of cartilage regeneration using stem cells and collagen, hyaluronic acid. For bone regeneration, he performed clinical trial as a principal investigator using autologous cultured osteoblasts for delayed union of fracture patient successfully in 2009. This is also world 1st clinical trial in that field.

Dr. Masataka Kinjo’s is affiliated with Faculty of Advanced Life Science, Hokkaido University. His main interest is in system of molecular interaction and recognition between biomolecules. Besides the development of single molecular techniques such as fluorescence correlation spectroscopy (FCS), fluorescence cross correlation spectroscopy (FCCS) and other techniques, he aims at the quantitative analysis of protein dynamics and interactions in living cell using FCS and FCCS.

Alexander Klibanov received his M.S. in Chemistry and Ph.D. in Chemical Enzymology both from Moscow University in Russia. Following his immigration to the United States in 1977, he spent 1.5 years as a postdoctoral associate in the Department of Chemistry at the University of California, San Diego, before joining the faculty at the Massachusetts Institute of Technology (MIT) where he is currently an Endowed-Chaired Professor of Chemistry and Bioengineering. His current research interests include medicinal chemistry, new antimicrobial materials; enzyme chemistry and biotechnology; and pharmaceutical formulations. He has authored over 310 scientific papers and 21 issued U.S. patents (plus many pending), has given over 370 invited presentations, including many named lectures all over the world, and is a member of 12 journal editorial boards. Dr. Klibanov has received numerous prestigious professional awards, including the Leo Friend Award, the Ipatieff Prize, the Marvin J. Johnson Award, and the Arthur C. Cope Scholar Award, all from the American Chemical Society, as well as the International Enzyme Engineering Prize. He was elected both to the National Academy of Sciences and to the National Academy of Engineering of the United States. Dr. Klibanov has started six pharmaceutical companies and has been a scientific advisor, consultant, and/or director for numerous pharmaceutical, medical device, and biotechnology companies.

Dr. Suresh Kumar has degrees in Microbiology (B.Sc.), Life sciences specialization in biomacromolecules (M.Sc.) and Microbiology (Ph.D.). He is currently working as an Associate Professor in Universiti Putra Malaysia, Malaysia. He has been a Post-Doctoral Research Fellow at National Central University and National Taiwan University, Taipei-Taiwan in the field of yeast genetics and Stem cells. His research interests have focused on Host-pathogen interactions, Stem cells with Infectious diseases, Infectious Diseases in Tuberculosis, Dengue and Leptospirosis, Bio-macromolecules, Yeast genetics, Fermentation and purification of Microbial drugs and enzymes, Stem cell niches, Induced Pluripotent stem cells. So far, he has published nearly 150 international publications.

Dr. Li got his PhD degree from Peking Union Medical College and did his postdoctoral training at the MIPS (Molecular Imaging Program at Stanford) and the Department of Radiology at Stanford University. Currently Dr. Li is a Professor in the Department of Pathophysiology and Director of the Laboratory of Molecular Imaging and Stem Cell Therapy at Nankai University School of Medicine, Tianjin (China). He has published more than 70 peer-reviewed papers on molecular imaging and stem cell therapy and his work was funded by several key grants from National Key Scientific Program of China and National Natural Science Foundation of China.

Prof. Li Volti graduated from the school of Medicine and obtained a doctorate (PhD) in Pediatrics at the University of Catania, Italy. Currently Prof. Li Volti is Associate Professor at the school of Medicine of the University of Catania and he is also chairman of the Department of the EuroMediterranean Institute of Science and Technology of Palermo (Italy). He has published more than 150 scientific publications and serves as a reviewer for several peer-reviewed journals. He is also Associate Editor of Frontiers in Pharmacology and member of the editorial board of PlosOne and Medicine.

Jonathan Lovell is an Associate Professor in the Biomedical Engineering Department at UB. He received his PhD from the Institute for Biomaterials and Biomedical Engineering from the University of Toronto in 2012 in the lab of Gang Zheng. Previously, he completed his MSc in Biochemistry at McMaster University in Hamilton, Ontario and his undergraduate degree at the University of Waterloo in Systems Design Engineering.

Dr. Jesús Fernández Lucas studied chemistry in Universidad Autónoma de Madrid (2002), and obtained PhD degree in Pharmacy from Universidad Complutense de Madrid (2008), with several pre and postdoctoral stages from some of the important research institutes, such as CBSMO-UAM or Pasteur Institute. In 2013, he created the Applied Biotechnology Group (Universidad Europea de Madrid), focused on the biocatalytic and biomedical applications of enzymes from purine and pyrimidine salvage pathway.

Dr. Haripada Maity is currently working as the Director, Biologics Development at Jazz Pharmaceuticals. Haripada also worked at Bioverativ – A Sanofi Company, Sanofi, ImClone Systems and Eli Lilly with a combined industry experience of about 15 years. Before joining biotech industry in 2006, he spent about 8 years in academia (post Ph.D.) and performed his major postdoctoral research in the Department of Biochemistry and Biophysics at the University of Pennsylvania School of Medicine, USA. Therefore, Haripada has about 23 years of post Ph.D. research and development experience in the area of Biologics Development including formulation and drug product development, biophysical and analytical development, Comparability assessment, protein folding/unfolding studies, hydrogen exchange monitored by NMR, structure-function relationships, protein-ligand interactions, and protein-protein interactions, resolving challenges in downstream process development, and multiple regulatory submissions. Haripada obtained his Ph.D. from Tata Institute of Fundamental Research, India. Haripada was awarded Extraordinary Effort Award of Lilly NJ twice. He was also awarded BHU Medal (Gold Medal) from Banaras Hindu University, India. At present, Haripada has already authored/co-authored thirty articles in scientific journals/Book. Haripada has presented multiple external presentations on pharmaceutical research as an invited speaker including the role as chairperson and panelist. He is an Editorial Board Member of the journal “Current Pharmaceutical Biotechnology”.

Dr. Francesco Marampon obtained his Ph.D. degree in Experimental Medicine and Endocrinology from the Department of Experimental Medicine, Histology and Embryology, University of L’Aquila, L’Aquila, Italy. Since 2017, Dr. Marampon is Postdoctoral Research Fellow in the Department of Radiotherapy at the Sapienza University of Rome, Rome, Italy. His skills and expertise mainly lie in the subject areas of Cancer Biology, Apoptosis, Oncology, Cancer Cells, Prostate Cancer, Radiation Oncology, Radiotherapy, Oncogenes, Cancer Stem Cells, etc. Dr. Marampon, as an author/co-author, has published more than 55 articles in various journals, having over 825 total citations.

Dr. Hongxue Meng did Clinical medicine, MD and Masters in pathology from Harbin Medical University in the period of 2001 to 2010. He is currently an Associate professor at the department of Pathology, Harbin Medical University Cancer Hospital. Also since 2017, he is a the Chief Professor at the Precision Medical Center, Harbin Medical University Cancer Hospital.

Dr. Luca Morini has obtained Ph.D. in Biomedical and Translational Science from the University of Verona, Italy in 2009. He has been serving as an Assistant Professor at University of Pavia since 2015. His main research interests are in the development and validation of LC-MS/MS procedures for the determination of xenobiotics in biological matrices, as well as the evaluation of different ethanol direct metabolites, as potential markers in alcohol acute and chronic abuse diagnosis. He has contributed more than 45 publications, having citations around 1,152.

Mohammad Hossein Morowvat, got his Pharm.D from the school of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran, in 2008 and his Ph.D. in Pharmaceutical Biotechnology at the School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He has been working as an Assistant Professor at Pharmaceutical Sciences Research Center and Department of Pharmaceutical Biotechnology, Shiraz University of Medical Sciences, Shiraz, Iran. He is a principal investigator working on different aspects of microalgal biotechnology such as green energy production, screening the naturally isolated microalgal strains for antioxidants, anti-bacterial and antiviral agents. Besides, he is interested in different cosmeceutical and biocosmetics production from the extracted bioactive compounds from the microalgae. He has published more than 80 original and review research papers, 100 abstracts and proceeding and 110 gene bank insertions at the NCBI database and more than 30 defensed dissertations and thesis.

Dr. Mulert was an Elective student at the National Hospital of Neurology, London, 1998. He is a visiting associate professor in the psychiatry department at Harvard Medical School, 2008 and a professor psychiatry University Clinic Hamburg, 2009. He is particularly interested in the neurophysiological and neurochemical mechanisms involved in visual perception. A particular interest is also to characterize possible changes in the context of schizotypy.

Prof. Musumeci obtained a doctorate (Ph.D.) in Human Movement Sciences from the University of Catania Medical School, Italy. Currently, Prof. Musumeci is Associate Professor (Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, School of Medicine), Deputy Dean (Human Movement Sciences School) and Director (Master’s School in Posturology and Movement Sciences) at the University of Catania, Italy. He has published more than 150 scientific publications and serves as an editor and reviewer for several peer-reviewed international journals and projects.

François Niyonsaba is a professor at Juntendo University. His research interests include investigation of immunomodulatory functions of antimicrobial (host defense) peptides in host defense against immunity using animal models and primary cells. He has published more than 100 papers, reviews and books, including papers in the world’s leading journals, and has 10 patents awarded. His numerous awards include: International Cytokine Society Outstanding Scholar Award; Takamitsu Sekine Research Award; Excellent Young Researchers Overseas Visit Program from the JSPS; Naito Foundation Fellowship, and Award for Excellence from the Eastern Asia Dermatology Congress. He is also a scientific consultant in two pharmaceutical companies.

Dr. Ilkay ERDOGAN ORHAN is presently acting as DEAN -Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Eastern Mediterranean University. She has published 166 research and review articles in reputed international journals and 11 book chapters. The research interests include Enzyme inhibitors from natural sources (plants and marine organisms), neurodegenerative diseases, marine natural products, natural cosmetics, phytotherapy.

Dr. Sujogya Kumar Panda is currently working as a postdoctoral at KU Leuven since 2014. Formerly, a faculty member at M.P.C (A) College and North Orissa University (India), University of Pavia (Italy), he has an eclectic background that includes teaching & research (Drug discovery, ethnopharmacology, infectious diseases, nanoparticles and pharmacoepidemiology). His current research interest includes i) Drug discovery from natural products; ii) Antimicrobial resistance; iii) Host-pathogen interaction; iv) Biofilm and anti-biofilm agents; v) Nanomedicine and herbal medicine vi) Anti- microbial peptides, vii) Essential oils and viii) Aging.

Dr. Jayanta Kumar Patra, M.Sc. Ph.D., PDF, is currently working as Assistant Professor at Dongguk University, Republic of Korea. His current research is focused on nanoparticle synthesis by green technology methods and their potential application in bio-medical and agricultural fields. He has about 12 years of teaching and research experience in the field of food, pharmacological and nano-biotechnology. Dr. Patra has published more than 100 papers in various national and international peer-reviewed journals along with 25 book chapters in different edited books. Dr. Patra has also authored 10 books in various publications. Besides, he is editorial board member of several International Journals.

Beatriz Pelaz is a research associate at the Center of Biological Chemistry and Molecular Materials and the Department of Physics of particles at the University of Santiago de Compostela since 2017. Her research is focused on the application of new materials in biology and medicine. She graduated in Chemistry from University of Valladolid and Biochemistry from University of Zaragoza. After she carried out her PhD studies at the Institute of Nanoscience of Aragón (INA, University of Zaragoza), in 2012, she moved into the group of Prof. Wolfgang J. Parak at the Philipps-University of Marburg, where she was awarded a Humboldt Fellowship.

Prof. Gianfranco Peluso graduated magna cum laude and special mention in Medicine at the University of Naples, Italy. He has been Director of the Department of Experimental Oncology at the National Cancer Institute and has coordinated the Italian Chapter of the European Glioblastoma Research Group. Currently, he is Research Director at Italian National Research Council. His scientific activity and areas of interest include: mitochondrial metabolism and how it is modulated by nutrients, drugs, etc.; carnitine system in healthy and pathological conditions; nanoscience and nanotechnology applied to medicine.

Yan Peng, MD, PhD is a Professor of Pathology at UT-Southwestern Medical Center. She serves as Pathology Liaison at Cancer Committee of the Simmons Cancer Center and University Hospitals. She is President of North Texas Society of Pathologists 2018-2019 and President of International Association of Chinese Pathologists 2017-2018. She served as Medical Directors for CLIA certified Immunohistochemistry, Image Analysis and FISH Labs for about 10 years. Her research is focused on diagnostic, prognostic, and predictive biomarkers in breast cancer and gynecologic cancer. She has authored over 70 peer-reviewed articles and several book chapters. She is an Editor-Board Member in multiple scientific journals.

Prof. Peng Huang received his PhD in Biomedical Engineering from the Shanghai Jiao Tong University in 2012. Then he joined the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institutes of Health (NIH) as a postdoctoral fellow. In 2015, he moved to Shenzhen University as a Distinguished Professor. His research focuses on the design, synthesis, and biomedical applications of molecular imaging contrast agents, stimuli-responsive programmed targeting drug delivery systems, and activatable theranostics. Starting from 2008, Dr. Huang has authored over 100 peer-reviewed papers, which have received a total citation of > 5,000 times and given him an H-index at 39.

Dr. Pico is the Head of the Neonatology Service and Director of the Diagnostic and Treatment Unit of Congenital Metabolic Diseases of the Hospital Clínico Universitario de Santiago de Compostela (Spain). She is currently working as an Associate Professor at the University of Santiago de Compostela. She is the leader of the neonatology and metabolopathies research group of the Sanitary Research Institute of Santiago, belonging to the ISCIII. Her research interest includes Neonatology and Hereditary Metabolic Diseases Neonatology and Hereditary Metabolic Diseases.

Dr. Colin Pouton is a Professor of Pharmaceutical Biology and Theme Leader: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences. His research focusses on the use of stem cells, and cells derived by differentiation of stem cells, in drug discovery. Differentiation of pluripotent stem cells to derive brain cells (particularly neurons and microglia)

Dr. Qadir has developed a new cost-effective and convenient method for diagnosis of cancer named as “Qadir test”. Dr. Qadir has also invented two anti-HIV drugs that may be used as prophylaxis or for the treatment of AIDS, especially for Pakistani’s patients. Dr. Qadir has worked to evaluate the pharmacological activities of local plants. He has established use of many local plants for cancer, jaundice/hepatitis, hypertension, asthma, diabetes, spasm, ulcer, fever, diarrhea, and infectious diseases of bacterial and fungal origin. Dr. Qadir has also worked on the isolation and structure elucidation of bioactive substances from medicinal plants and has resulted in the discovery of several new/novel natural compounds. Dr. Qadir has patents for Preparations containing locally isolated bacteriophages (Qadirphages) with their antibacterial activity. Dr. Qadir has increased the efficacy of many drugs with the use of nanotechnology and polymer-technology. Dr. Qadir has identified different biological and pharmacological pathways which are important for diagnosis and management of different diseases. Dr. Qadir has more than 190 publications, making an impact factor more than 100, and supervision of 02 PhD and 35 M Phil theses.

Dr. Ranzato obtained his Ph.D degree from University of Piemonte Orientale. He is currently working as Fixed-Term Researcher in Cell Biology at University of Piemonte Orientale. He has the honor of receiving Junior Researcher Award from Italian Association for Cell Culture. Dr. Ranzato has developed an in vitro, human wound-healing model able to investigate the effects of various agents and experimental conditions on the wound re-epithelialization process. He is currently using both platelet derivatives and natural compounds, as experimental tools, in order to perform a more in-depth analysis, in terms of cell biology and proteomics, of the mechanisms of wound healing. He has an h-index of 15 and currently serving as an editorial board member of many scientific journals.

Dr. Eva Reali is currently a visiting Scientist at Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy. She received Master Degree in Pharmacy from University of Ferrara, Italy in 1989 and Ph.D. Program in “Cellular and Molecular Pharmacology” from Faculty of Medicine, University of Ferrara, Italy in 1996. She has numerous honors/awards and publications to her credit.

Filippo Rossi is Assistant Professor at the Department of Chemistry, Materials and Chemical Engineering “Giulio Natta” at Politecnico di Milano (Milano, Italy). In February 2011, he received Ph.D. in Chemical Engineering from the Politecnico di Milano with honors with an experimental thesis on polymeric devices able to control and sustain the release of cells and drugs in spinal cord injury treatment. He also spent his research period as a visiting Ph.D. student at Imperial College, London. He worksas Assistant Professor at Politecnico di Milano and as Guest Researcher at Istituto di Ricerche Farmacologiche Mario Negri. His main research interests are in the field of innovative polymer materials for nanomedicine, drug delivery and tissue engineering with experimental and model studies.

Dr. Ruvo graduated in Chemistry from the University of Naples in 1991. He spent the first 10 years of his career as industrial researcher (Tecnogen, Italy), working as head of the protein and peptide laboratory and contributing to the development of several bioactive peptides. In 2002, he joined the Institute of Biostructures and Bioimaging of the National Research Council (IBB-CNR) in Naples, working as senior scientist and leading several projects aimed to develop of new bioactive peptides and monoclonal antibodies against targets with a role in cancers development. Among the others, he has developed peptides modulating the activity of PlGF, Cripto, and Gadd45β and mAbs against Nodal, the E2 protein of HCV and Cripto. He is also the scientific founder of Kesios Therapeutics Ltd (London). He is author of about 100 papers and inventor of >10 patents.

Dr. Seiichi Sakamoto received his Ph.D. degree in Pharmacy from Kyushu University in 2011. Then, he joined Nagasaki International University as Research Associate. In 2013, he moved to Kyushu University as Assistant Professor. His research interest includes allelopathy, phytochemical analysis using immunoassay, antibody engineering, and anti-cancer activity. Dr. Sakamoto has authored over 60 peer-reviewed papers.

G. Sanchez-Duffhues was graduated in Biochemistry and obtained his PhD in 2011 at the University of Cordoba (Spain), where he focused on (semi)synthetic compounds regulating inflammatory cell responses. After his PhD, he joined the group of Prof. Peter ten Dijke at the Leiden University Medical Center (LUMC, Leiden, The Netherlands), where he studied the mechanisms by which aberrant cell responses to members of the Transforming growth factor (TGF)-beta family, together with other signaling pathways, contribute to bone and vascular pathologies. Currently, he works as a Senior Scientist at the Department of Cell and Chemical Biology of the LUMC.

Dr. Karuna Shanker is a Principal Scientist at CSIR-CIMAP, INDIA. His primary research interest is to investigate the Indian medicinal plants for new chemical entities (NCEs bioactive/chemotaxonomic) using chromatographic & spectroscopic techniques. The secondary objective is to establish a possible mode of action/mechanisms behind biological activity as well as validation of traditional medicinal/therapeutic claims. He has published more than 50 articles in well-reputed journals.

Hari Shanker Sharma, Director of Research (International Experimental Central Nervous System Injury & Repair, IECNSIR), University Hospital, Uppsala University is Professor of Neurobiology (MRC), Docent in Neuroanatomy (UU) and is currently affiliated with Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, Uppsala University, Sweden. His current research on nanobiotechnology is supported by European Aerospace Research and Development (EOARD), London, UK and US Air Force Research Laboratory, Wright Patterson Air Force Base, Dayton, OH, USA. Dr. Sharma published over 400 research papers (H-index 43), and serving editor of Progress in Brain research series and International review of Neurobiology.

Dr. Xuetao Shi is a full professor in the Department of Biomedical Engineering at South China University of Technology. Dr. Shi revised his Ph.D. at South China University of Technology in China. He was a Postdoctoral Associate working at Tohoku University in Japan. He has been appointed as an assistant professor in the same university before he joined South China University of Technology. His group studies controlled drug delivery, biomaterials and tissue engineering, especially for bone and cartilage threatment. He has published over 70 research papers in Angewandt chemie, Advanced Materials, Advanced Functional Materials, Biomaterials et al .

Dr. Uğur Tamer is a Professor of Pharmacy Faculty at Gazi University in Turkey. He received Ph.D. in 2003 from the Hacettepe University in the Department of Analytical chemistry. Under the mentorship of Professor Dr. Kadir Pekmez and Professor Dr. Attila Yıldız, his research focused on modified electrodes and conducting polymers. He developed SERS based sensor in order to detect small and macromolecules in complex matrix such as blood or food. He was involved in the development of novel molecular recognition system suitable for optical and electrochemical system,.generation of high yield anizotropic hybrid nanoparticles and surface functionalization to detect pathogens or biological-chemical target. He is a member of three COST actions. He has published 126 peer-reviewed research papers and 3 book chapters.

Dr. Anna Tesei, PhD, MSc, is a Biochemist/Cell Biologist, employed at the Biosciences Laboratory of IRST-IRCCS holding the position of Head of Drug Discovery and Radiobiology Unit. She has over 20 yrs of research experience in study of antineoplastic drug action mechanism, drug resistance, preclinical development of new anticancer molecules. Her current research interests include the set-up of in vitro 2D /3D tumor models for drug therapeutic screening and radiobiological investigations, isolation of cancer stem cells and the research on self-renewal and stemness maintenance. She has authored over 70 scientific paper and 2 issued US Patents, and she is editorial board member of 2 journals.

Gian Mario Tiboni, MD, is associate professor of Obstetrics and Gynecology at the School of Medicine at the University of Chieti Pescara, Italy. He has published more than 70 scientific publications in peer-reviewed journals. He is currently director of the Assisted Reproduction Technologies Unit at the University of Chieti Pescara. Dr. Tiboni has research interest in infertility, assisted reproductive technology and reproductive toxicology.

Valery V. Tuchin is a Professor and Head of Optics and Biophotonics at Saratov State University (National Research University of Russia) and several other universities. His research interests include tissue optics, laser medicine, tissue optical clearing, and nanobiophotonics. He is a fellow of SPIE and OSA, has been awarded Honored Science Worker of the Russia, Honored Professor of Saratov University, SPIE Educator Award, FiDiPro (Finland), Chime Bell Prize of Hubei Province (China), NanQiang Life Science Series Lectures Award of Xiamen University (China), and Joseph W. Goodman Book Writing Award (OSA/SPIE).

Prof. Turillazzi is an Italian Citizen. She is chief of the Section of Legal Medicine, University of Pisa, Italy. Prof. Turillazzi main research interests are generally in Medical Ethics and Forensic Pathology. She is author and co-author of an extended number of papers published in major national and international scientific journals. Her primary research achievements are related to her studies on forensic pathology, cardiovascular pathology, drugs abuse, medical liability and bioethics.

Paola Ulivi is graduated in Medical Biotechnology (2000) and in Molecular and Cellular Biology (2009). She obtained a Master degree in Pharmacology (2006) and a PhD in Pharmacological and Tossicological Sciences (2014). She works as researcher at Biological Laboratory of the Department of Medical Oncology, Morgagni-Pierantoni Hospital, Forlì, from 2001 to 2008, and from 2008 to now at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola. She is specialized in the field of molecular biology and translational research, in particular in lung cancer and gastrointestinal tumors.

Dr. Jinxiang Xi is an Associate Professor of Biomedical Engineering at UMass Lowell. He obtained his Ph.D. in Mechanical Engineering from Texas A&M University in 2005. Before joining UML, he has worked as an Assistant Professor at the University of Arkansas, Little Rock and Central Michigan University and an Associate Professor at California Baptist University. Dr. Xi has sixteen years of research experience in biomedical devices and pharmaceutical research. His research in respiratory aerosol dynamics is highly interdisciplinary, which bridges biology, medicine, and engineering. Applications include inhalation toxicology, aerosol-based tumor diagnosis, and personalized drug delivery. Dr. Xi won the 2012 Monaghan-Trudell Award from the American Respiratory Care Foundation for his contributions to “Aerosol Technology Development”.

Dr. Jianqiang Xu is currently active as an associate professor of biochemistry in School of Life Science and Medicine and as Vice Director of Panjin Industrial Technology Institute at Dalian University of Technology (DUT). He completed his B.S. degree in 2002 and Ph.D. degree in 2008 with Professor Qing Yang at DUT. From 2009 to 2014, he received PostDoc training with Professor Elias Arnér (Karolinska Institutet, Sweden). In 2015, he started his independent research career at Panjin Campus of DUT. His research mainly focuses on selenium biology and its biological and medical applications to solve health and disease issues.

Jean-Ralph Zahar is an infection control practitioner working in teaching hospital since 2004. His research interests are, ESBL infection, health acquired infection in ICU and antimicrobial stewardship. He is a member of the UMR 1137 - IAME Team 5 – DeSCID: Decision SCiences in Infectious Diseases, control and care Inserm/Univ Paris 13, Sorbonne Paris Cité.

Dr. K. Baskar is presently serving as a Manager at Ross Life Sciences Pvt. Ltd Pune India. He has completed his PhD in Entomology-Zoology from Entomology Research Institute Loyola College, University of Madras, Chennai, India. He is specialized in the field of agriculture and household Entomology and Ecotoxicology. He has 16 years of research experience including 6 months teaching experience. He has published more than 85 papers in the field of entomology especially in agriculture pest management and ecotoxicology. He is also serving in the editorial advisory board of Physiological and Molecular Plant Pathology and reviewer in a few international journals including Journal of Economic Entomology, Scientific Report and Industrial Crops and Product etc.

Claudio gained a PhD in Genetics, Oncology and Clinical Medicine at the University of Siena, Italy in 2013. His work was focused on the molecular pathogenesis of autoimmune rheumatic diseases. He then worked in the Department of Medicine, Surgery and Neuroscience of University of Siena as PostDoc fellow between 2013 and 2016, learning the most important techniques related to human tissue engineering and regenerative medicine. In 2016 he joined Galapagos BV in The Netherlands as a Scientist and Project Leader in the Target Discovery and Validation Department. In October 2018 Claudio joined Exosomics S.p.A. in Siena as Head of Translational Science & Medical Affairs. He still leads the research department of the Scleroderma Unit of the University-Hospital of Siena.

After Eduardo Fernández-Martínez had completed his studies of bachelor's degree as a Pharmaceutical Engineer, he worked in the pharmaceutical industry as a researcher on medicines design and pharmaceutical technology. Later, he earned both the Master of Sciences and the Doctor of Sciences degrees in Pharmacology. His research interests are mainly focused on the obtention and pharmacological evaluation of synthetic compounds, natural products, or known drugs as immunomodulatory and antioxidant hepatoprotective agents. Besides, the obtention and assessment of compounds as tocolytic agents which act by the same mechanisms of action and as uterus-relaxants has been approached.

Dr. Alexsandro Galdino received his Biological Sciences degree from Universidade Federal do Ceará (Brazil) and a doctoral degree from the Universidade de Brasília (UnB) (Brazil). He conducted his post-doctoral research at UnB (2008-2010) and has been a professor at Universidade Federal de São João Del-Rei (Brazil) since 2010. During his studies, Dr. Galdino dedicated efforts in the field of cloning and heterologous gene expression in microorganisms (bacteria and yeasts) to obtain innovative products for industries. Dr. Galdino is involved in the production of recombinant industrial enzymes for several biotechnological applications as well as antigenic targets as input for immunological diagnosis kits.

Dr. Prashant Mohanpuria has been Assistant Professor of Biotechnology at Punjab Agricultural University, Ludhiana, India since 2012. He received his doctorate degree from I.H.B.T. (CSIR) Palampur, India in 2012 and has served as a Reviewer for more than 10 international journals for the last eight years. He has published more than 30 articles in peer-reviewed international journals. The present research interests of his team include agricultural biotechnology involving citrus limonoid and tomato oxalate metabolic engineering for human health, pest insect resistance using RNAi, crop quality improvement using genome editing.

Dr. Giandomenico Roviello MD is a medical oncologist of the Division of Medical Oncology, Department of Oncology, University of Trieste Hospital. He worked as a research assistant at University of Brescia, Section of pharmacology and University Center DIFF-Drug Innovation Forward Future, department of Molecular and Translational Medicine and of Unit of Medical Oncology, Department of Oncology, Medical Oncology Unit, San Donato Hospital, Arezzo, Italy. He graduated from the School of Medicine, Second University of Naples in 2008, after he graduated as medical oncologist from University of Siena in 2015 and finally he achieved PhD in Molecular Biomedicine from University of Trieste. Dr Roviello current research interests are genitourinary oncology (particularly prostate cancer), gastric cancers and Immunotherapy.

Dr. Leming Sun is an associated professor in Northwestern Polytechnical University, China. He obtained his Ph.D. degree from The Ohio State University, USA. His research interests focus on peptide self-assembled functional nanomaterials for bio-imaging, drug delivery and regenerative medicine; bioinspiration/biomimetic technology and biomedical application, disease diagnosis and therapy. He has published more than 30 peer-reviewed research papers.

Emanuel Vamanu is working as an Associate Professor at the UASVM Bucharest Romania, Faculty of Biotechnologies since 2016. His research interests revolve around Fermentative technologies, pharmaceutical fermentative biotechnologies, probiotic strains and prebiotic characterization, in vitro tests, human gastrointestinal tract simulation, industrial drug production, conditioning drugs, the bioavailability of drugs, correlations in vitro/in vivo, biotechnological processes, in vitro activity of functional food, and biopharmaceutical products. He has published six specialized books, 90 articles in scientific journals, author of eight patents, and presented over 80 papers at scientific conferences.

Rituparna Acharya has done her post-graduation in Management from Indira Gandhi National Open University, along with a post-graduation in Zoology as well. Moreover, she has a diploma in Optometry from Jadavpur University, Kolkata, after which she completed her M.Phil from Jadavpur University on Oceanography and Coastal Management. She was awarded a gold medal for her outstanding achievement in M.Sc. She has more than 13 publications in the field of life sciences and 5 publications in the field of management in different national and international peer-reviewed journals. Moreover, she is pursuing double PhD at Jadavpur University on Bioscience and Engineering and on Management in Seacom Skills University.

The experienced researcher with a demonstrated history of researching in the field of pharmaceutical sciences. Skilled in clinical research, Animal models, Cellular models, Scientific writing & publishing. He has focused on extensive fields of Pharmacology & Toxicology, Natural products, Radiopharmaceuticals, Nanomedicine, Radiation biology, Cancer chemoradiotherapy and other fields of Pharmacy at the Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. He has published many originals and reviews in high-quality journals and selected as a recognized international editor and peer reviewer by famous publishers. In 2019, Dr. Amirhossein Ahmadi certificates for placing in the top 1% of reviewers in Cross-Field on Publons global reviewer database.

Dr. Selvaraj Arokiyaraj is an assistant professor in the Department of Food Science and Biotechnology, Sejong University, Seoul, South Korea. He completed his B.Sc. in Microbiology in 2002 and M.Sc. in Biotechnology in 2004 from the University of Madras and then achieved his Ph.D. in Life Sciences – Microbiology from Sathyabama University in 2011. Overall, he has a total of 10 years of teaching & research experience. He has an H index of 17 and has authored/co-authored over 29 publications, with Citation index >1000 and published 3 chapters in books. He has professional membership with the Korean Society of Animal Sciences, South Korea and Indian Science Congress, India. Dr. Arokiyaraj acted as a Reviewer in various peer review international journals.

Dr. Md. Abul Barkat is an assistant professor in the department of Pharmaceutics, College of Pharmacy, University of Hafr Al-Batin, KSA. He obtained his Ph.D. in Pharmaceutics, from Integral University, Lucknow, India, with the thesis entitled: “Development of Novel Nanostructured Drug Delivery System of Silver Sulfadiazine containing Aloe Vera Gel for the treatment of Burns/wound”. His research interests / expertise mainly lie in the subject areas / fields pertaining to Pharmaceutics including Nano Drug Delivery System, Herbal Nanoformulations, Metal based nanoparticles, Targeted Drug Delivery Systems, Formulation development, Scale-up, and Technology transfers, and focused on diseases: Burn wound, cancer, neuroblastoma etc. He has actively participated in numerous research and review article publications. Furthermore, Dr. Barkat has authored / co-authored 8 books (international & national) and 10 book chapters.

Prof. Dr. Ratiram Gomaji Chaudhary is currently working as Assistant Professor and Head of the Post Graduate Department of Chemistry, Seth Kesarimal Porwal College of Arts, Science and Commerce, Kamptee. His research areas of interest are biogenic synthesis, bioinspired nanomaterials, metal oxide/graphene-based nanomaterials, photocatalysis, organic transformation, antimicrobial assay, and docking. He has completed one Major Research Project funded by SERB. He is a recognized supervisor of RTM Nagpur University, Nagpur, and supervised five Ph.D. students, while five PhDs are still working and 45 MSc students completed projects-dissertation under his guidance. He has been awarded two times with the Rajiv Gandhi National Fellowship. He has published two books, TEN chapters, and more than 85 regular articles, and 10 review articles in the peer-reviewed journals. He has received awards such as being a recipient of the Young Scientist Award. He is a reviewer of more than 35 peer-reviewed journals of reputed publishers. He worked as a guest editor for Material Today: Proceeding, Elsevier, Current Pharmaceutical Biotechnology, Bentham Science, and presently working as guest editors for peer-reviewed journals. Moreover, he has delivered several invited talks and chaired the session at the national and international conferences/webinars.

Dr. Giulia Marrone has been affiliated with the Department of Biomedicine and Prevention, Division of Clinical Nutrition and Nutrigenomic, University Tor Vergata of Rome, Italy. She did Ph.D. in Clinical Nutrition and Nutrigenomics. Currently, she is a Research Fellow at Tor Vergata University. She has expertise in Clinical Nutrition for the Prevention and Treatment of Chronic Non-Communicable Diseases. Her area / field of interest is Renal Nutrition, Chronic Non-Communicable Diseases Preventive Nutrition, Metabolic Syndrome Nutritional Treatment, Oxidative Stress and Diet, Chronic Low-Grade Inflammatory Status and Diet, and Impact of Minor Polar Compounds on Human Health etc. To date, she has authored / co-authored nearly 30 articles in various journals.

Annalisa Noce, MD, PhD, is assistant professor of Nephrology at the University Tor Vergata of Rome (Italy), Department of Systems Medicine. Annalisa Noce’s research activity involves clinical nutrition in chronic kidney disease (CKD), with particular focus on the effects of nutritional therapy on CKD progression and oxidative stress, in nephropathic patients and gender medicine in chronic non-communicable diseases (CNCDs). Moreover, she is expertise in renal Doppler Ultrasonographic examination for the determination of renal resistive index. Her main studies investigate on the impact of some nutritional therapies (such as low-protein diet, bioactive natural compounds, Italian Mediterranean diet and gut microbiota in CNCDs etc.) and lifestyle changes on the onset and the progression of CNCDs. She is author of over 50 publications with H index of 17 (Scoups source). She is also a guest editor for international Journals, as Nutrients (MDPI) and reviewer for BMC Nephrology, Acta Diabetologica and Clinical Nutrition journals.

Dr. Alessandro Santurro is currently working in the department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Section of Forensic and Legal Medicine, Sapienza University of Rome, Italy. He completed his Ph.D. in Infectious Diseases, Microbiology and Public Health from Sapienza University of Rome. His occupational fields of interest are Forensic & Legal Medicine and Forensic Pathology. Dr. Santurro has scientific contributions in various national and international journals. He has published over 25 manuscripts accumulating over 159 citations, with an h-index of 8. His research / field of interest mainly falls on Forensic pathology, sudden cardiac death, molecular mechanisms, traumatic brain injury, oxidative stress; immunohistochemistry, drug abuse, maternal mortality, miRNA, postmortem imaging, post-mortem computed tomography (PMCT), post-mortem magnetic resonance (PMMR), wounds vitality, personalized medicine, bioethics, forensic toxicology.

Dr. Shriram is recognized as an eminent scientist and bright academician having sound administrative acumen. He is a person of integrity, vision and foresight to lead any Institute to new heights in qualitative as well as quantitative growth. He is working as a Faculty in the Department of Chemical Engineering in Visvesvaraya National Institute of Technology Nagpur from 2008 to till date. He has served as faculty in reputed institutions like Dr. BATU lonere Raigad, (M.S.), UDCT NMU, Jalgaon, SSBT'S Jalgaon and now in VNIT Nagpur with total teaching experience of more than 15 years.

Dr. Jianqiang Xu is currently active as an associate professor of biochemistry in School of Life Science and Medicine and as Vice Director of Panjin Industrial Technology Institute at Dalian University of Technology (DUT). He completed his B.S. degree in 2002 and Ph.D. degree in 2008 with Professor Qing Yang at DUT. From 2009 to 2014, he received PostDoc training with Professor Elias Arnér (Karolinska Institutet, Sweden). In 2015, he started his independent research career at Panjin Campus of DUT. His research mainly focuses on selenium biology and its biological and medical applications to solve health and disease issues.